AC Immune ACIU
NASDAQ ACIU
$2.60 -0.01 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

AC Immune (ACIU) Restructuring Costs (2021 - 2025)

Updated

AC Immune's Restructuring Costs was $15,014 in the quarter ended Dec 31, 2025.

Analysis

AC Immune (ACIU) Restructuring Costs (2021 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Restructuring Costs at AC Immune came in at -$548,788.

  • In earlier years, Restructuring Costs was $1.25 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2025 marks the highest quarterly Restructuring Costs since the quarter ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 AC Immune 265.55 Mn 265.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15,014.04
Sep 30, 2025 -583,801.14
Jun 30, 2021 449,625.32
API Access

AC Immune Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ACIU&period=max&api_key=YOUR_API_KEY